Beijing mairui medical equipment

At present, Mindray has a large winning volume, complete products and wide coverage, and the company is not bad after listing; The advantages of UIH lie in government relations and financing ability. After all, the background is unusual, but as far as products and R&D are concerned, the input and Mindray are not at the same level.

In the field of monitoring and in vitro diagnosis, Mindray has achieved No 1 in China, and some parameters and technologies are equivalent to those of foreign companies such as Roche and Beckman, which are also recognized by hospitals and distributors. At present, the influence of UIH products is still relatively low. Under the influence of the government, UIH signed several big orders, but image products need deep technical precipitation. At present, there is a big technical gap between state-owned enterprises and traditional general practitioners.

Now that the national policy supports domestic production, I believe that Mindray and UIH still have a lot of room for growth. Finally, apart from other treatments, UIH is not just Mindray.

Research and development (R&D)

Since its establishment, Mindray has always taken "meeting customers' needs" as the driving force for growth, and gradually established a research and development management platform with customers' needs as the guide and project management as the core, which is close to the market, fully understands users' needs, responds quickly, integrates innovative technologies and R&D production cost advantages, and provides high cost-effective products and services for global medical institutions and creates greater value for customers.

Mindray has established six R&D centers in Shenzhen, Beijing, Nanjing, Seattle, New Jersey and Stockholm. In Mindray, nearly 30% employees are engaged in R&D system and various products related to clinical application.

Mindray insists on investing about 65,438+00% of its annual turnover in supporting product innovation and R&D, and has established a research and development management platform synchronized with international first-class standards.

Mindray has a research and development management process that conforms to CE, FDA standards and ISO system. The expert committee controls and manages the development process, designs all products according to relevant international standards, and conducts comprehensive special tests (including EMC, safety, environment, etc.). ) to ensure the safety and reliability of products.